Drug Patent Watch
OCTOBER 28, 2024
The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to streamline the drug development and manufacturing process. CDMOs provide a wide range of services that cater to the diverse needs of pharmaceutical companies, from early-stage development to commercial manufacturing.
Fierce Pharma
OCTOBER 28, 2024
Novartis and Apellis Pharmaceuticals have rolled out detailed data on iptacopan and pegcetacoplan, respectively, as they race for the prize in a type of rare kidney disease. | Novartis and Apellis dropped new data on their respective meds, iptacopan and pegcetacoplan, in the rare kidney disease C3 glomerulopathy. While Apellis' drug seems to have an efficacy edge based on a cross-trial comparison, Novartis may have gotten the jump by filing for approvals ahead of its competitor.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 28, 2024
Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class therapies for the disorder.Data reported at the Kidney Week 2024 congress in San Diego showed that felzartamab was able to achieve "substantial" reductions in proteinuria and stabilised kidney function in the 54-subject IGNAZ study that extended for 18 months after the last dose of the antibody.
Pharmaceutical Technology
OCTOBER 28, 2024
The enduring effects of redlining on public health, particularly on asthma prevalence, provide a striking example of how discriminatory housing policies from the 20th century continue to shape the well-being of marginalised communities affected by this practice today.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Bio Pharma Dive
OCTOBER 28, 2024
Assure the integrity and efficiency of your clinical trials with support from a Biospecimen Manager.
Pharmaceutical Technology
OCTOBER 28, 2024
The US FDA has approved Iterum Therapeutics' NDA for ORLYNVAH to treat uncomplicated urinary tract infections (uUTIs).
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
OCTOBER 28, 2024
Buying Aliada Therapeutics would hand AbbVie a clinical-stage Alzheimer’s medicine and a drugmaking technology that may be useful for a variety of brain diseases.
Pharmaceutical Technology
OCTOBER 28, 2024
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2024 is a strategic platform for discussion and collaboration among decision makers, researchers and technologists who understand and follow this tendency.
Bio Pharma Dive
OCTOBER 28, 2024
Novartis follows cross-town rival Roche in partnering with Monte Rosa Therapeutics on so-called molecular glue degraders that can target “undruggable” proteins.
Pharmaceutical Technology
OCTOBER 28, 2024
Ahead of the upcoming DSCSA November deadline, pharma companies reimagine track-and-trace to tackle the US counterfeit drug landscape.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
OCTOBER 28, 2024
Learn why print remains a preferred channel for healthcare communications, and how printed materials can help build relationships with patients, develop brand loyalty and maintain brand consistency.
Pharmaceutical Technology
OCTOBER 28, 2024
UPFs have become a staple of many diets worldwide, but overconsumption is contributing to an obesity epidemic in India.
Bio Pharma Dive
OCTOBER 28, 2024
With the new clinical trial diversity guidelines, the combination of EHR data and AI will be essential.
Pharmaceutical Technology
OCTOBER 28, 2024
As the retail drug pharmacy space undergoes significant change, new formats and designs that centre on the consumer are emerging.
pharmaphorum
OCTOBER 28, 2024
MSD and Moderna start a third phase 3 trial of their V940 cancer vaccine, their second in early-stage lung cancer.
Pharmaceutical Technology
OCTOBER 28, 2024
The US FDA has granted orphan drug designation (ODD) to Modalis Therapeutics’ MDL-101, aimed at treating LAMA2-CMD.
pharmaphorum
OCTOBER 28, 2024
Apple wins in patent infringement lawsuit with wearable maker Masimo, but fails to get the injunction on sales that it sought
Pharmaceutical Technology
OCTOBER 28, 2024
At the Outsourcing in Clinical Trials conference, Rohan Simon from the UAE CRO IROS, spoke about the region’s clinical trials landscape.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
pharmaphorum
OCTOBER 28, 2024
Discover the latest advancements in cell therapy with the next generation of innovative treatments that are revolutionising healthcare. Explore the future of medicine today.
Pharmaceutical Technology
OCTOBER 28, 2024
Motivated patients with rare diseases are using social media widely, making it an effective way to reach patients for trial recruitment.
pharmaphorum
OCTOBER 28, 2024
Novartis says Fabhalta shows sustained efficacy in rare disease C3G over 12 months, as it prepares for an FDA filing later this year
Pharmaceutical Technology
OCTOBER 28, 2024
Astellas has announced the withdrawal of its MAA for ACP from the EMA to treat geographic atrophy (GA) secondary to AMD.
pharmaphorum
OCTOBER 28, 2024
Astellas confirmed today it will withdraw its EMA filing for avacincaptad pegol as a treatment for eye disorder geographic atrophy in the EU
Pharmaceutical Commerce
OCTOBER 28, 2024
With the design of the new 360,000 square-foot building, the CDMO’s goal is to continue to modernize its Laupheim site.
pharmaphorum
OCTOBER 28, 2024
In a recent pharmaphorum webinar, we sat down with Melanie Walsh, Senior Director, IBD Franchise Customer Experience and Digital Innovation, at Takeda, to learn some tips for successful content transformation.
Pharmaceutical Commerce
OCTOBER 28, 2024
The latest news for pharma industry insiders.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
OCTOBER 28, 2024
Discover how the healthcare industry is raising customer experience standards through meaningful real-person communication. Learn why this approach is vital for patient satisfaction and better outcomes.
Pharmaceutical Commerce
OCTOBER 28, 2024
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
BioPharma Reporter
OCTOBER 28, 2024
Vicky Marriottâs journey from enjoying school math to heading a global team of statisticians at Phastar reveals her belief in the power of empathy and collaboration.
Pharmaceutical Commerce
OCTOBER 28, 2024
Albert Thigpen, co-founder, Talentwise Consulting, explains how to use these tactics in order to anticipate the future US healthcare policy environment.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Expert insights. Personalized for you.
109 
Let's personalize your content